Humacyte's market cap is currently ―. The company's EPS TTM is $-1.071; its P/E ratio is -3.45; Humacyte is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -23.39M	$ -24.49M	$ -21.00M	$ -36.75M	$ -3.55M
EBITDA	$ -21.46M	-	$ -18.95M	$ -34.27M	$ -1.08M
Net Income Common Stockholders	$ -25.14M	$ -25.95M	$ -22.71M	$ -36.98M	$ -3.77M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 80.45M	$ 99.99M	$ 114.60M	$ 131.68M	$ 151.88M
Total Assets	$ 128.22M	$ 149.38M	$ 168.10M	$ 182.98M	$ 204.30M
Total Debt	$ 57.51M	$ 56.78M	$ 56.32M	$ 50.52M	$ 50.70M
Net Debt	$ -22.94M	$ -43.21M	$ -58.28M	$ -81.16M	$ -101.18M
Total Liabilities	$ 114.68M	$ 112.39M	$ 107.03M	$ 101.09M	$ 87.37M
Stockholders Equity	$ 13.55M	$ 36.99M	$ 61.13M	$ 81.89M	$ 116.93M
Cash Flow	-
Free Cash Flow	$ -19.15M	-	$ -19.55M	$ -33.94M	$ -19.58M
Operating Cash Flow	$ -19.00M	$ -13.10M	$ -19.07M	$ -32.79M	$ -18.90M
Investing Cash Flow	$ -150.00K	$ -493.00K	$ -1.98M	$ 13.05M	$ 5.21M
Financing Cash Flow	$ -335.00K	$ -764.00K	$ 6.03M	$ -409.00K	$ -212.00K

Currency in USD

Humacyte Earnings and Revenue History

Income Statement >

Humacyte Debt to Assets

Balance Sheet >

Humacyte Cash Flow

Cash Flow >

Humacyte Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing